This page contains a Flash digital edition of a book.
Pluripotent Stem Cell Technology


Recent advances in stem cell technology utilize repeated mRNA transfection as a faster and more effi cient method to generate induced pluripotent stem cells (iPSCs) compared to DNA transfection, viral, or protein transduction.


Find out more in the following articles highlighting TransIT® in RiPSC Technology:


-mRNA Transfection Kit


• Angel M, Yanik MF. 2010. Innate Immune Suppression Enables Frequent Transfection with RNA Encoding Reprogramming Proteins. PLoS One. Jul 23;5(7):e11756.


• Warren L, et al. 2010. Highly Effi cient Reprogramming to Pluripotency and Directed Differentia- tion of Human Cells with Synthetic Modifi ed mRNA. Cell Stem Cell. Volume 7, Issue 5, 618-630.


100 120


20 40 60 80


0 A549 To inquire about the TransIT® -mRNA Transfection Kit,


Visit www.TheTransfectionExperts.com E-mail: techsupport@mirusbio.com or call 888.530.0801 (U.S. only); +1.608.441.2852 (outside the U.S.)


www.TheTransfectionExperts.com More than a decade of gene delivery expertise


©2011 All rights reserved Mirus Bio LLC. All trademarks are the property of their respective owners. TransIT® CHO-K1 COS-7 HEK293 HeLa NIH3T3 Vero


Cells. Cells were transfected at 80% confl uency with a capped, poly-A mRNA encoding fi refl y lu- ciferase using either TransIT-mRNA (Mirus Bio) or TransMessenger®


-mRNA Transfection Kit Provides High Effi ciency Transfection of Large RNA into Mammalian (Qiagen). Luciferase activity


(solid bars) was assayed 18 hours post-transfection and normalized against values obtained using TransIT-mRNA. Visualized cell confl uency at the time of harvest (black diamonds) was 100% using TransIT-mRNA compared to lower values using TransMessenger Reagent.


Find us on facebook Mirus Bio LLC—The Transfection Experts


TO ORDER | toll free 888.530.0801 | direct 608.441.2852 | www.TheTransfectionExperts.com


Validated RNA Induced


TransIT®


©2010 Mirus Bio LLC. All trademarks are the property of their respective owners. All rights reserved. -mRNA Reagent TransMessenger® Reagent Cell Confluency


Normalized Luciferase Activity


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92